T淋巴細(xì)胞在原發(fā)性硬化性膽管炎中的作用
打開(kāi)文本圖片集
摘要: 原發(fā)性硬化性膽管炎(PSC)是一種免疫介導(dǎo)的慢性膽汁淤積性肝病,可進(jìn)展為肝硬化和肝衰竭等終末期肝病,目前尚無(wú)有效的治療方法。研究發(fā)現(xiàn),T淋巴細(xì)胞與PSC的發(fā)生發(fā)展密切相關(guān)?,F(xiàn)對(duì)T淋巴細(xì)胞在PSC中的作用進(jìn)行綜述,以期為PSC發(fā)病機(jī)制的研究及臨床診療提供新的思路。
關(guān)鍵詞: T淋巴細(xì)胞; 原發(fā)性硬化性膽管炎; 發(fā)病機(jī)制
基金項(xiàng)目: 甘肅省自然科學(xué)基金(21JR1RA070); 蘭州大學(xué)第一醫(yī)院院內(nèi)基金(ldyyyn2020-02, ldyyyn2020-14); 甘肅省感染肝病臨床醫(yī)學(xué)研究中心(21JR7RA392); 甘肅省高等學(xué)校創(chuàng)新能力提升項(xiàng)目(2020B-016)
Role of T lymphocytes in primary sclerosing cholangitis
LI Ziyi1, ZHANG Wanjie1, WANG Fuchun1, MAO Xiaorong1,2a, LI Junfeng1,2a,2b. (1. The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; 2. a. Department of Infectious Diseases, b. Department of Infectious Diseases & Institute of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou 730000, China)
Corresponding authors: MAO Xiaorong, [email protected] (ORCID: 0000-0003-1952-1554); LI Junfeng, [email protected] (ORCID: 0000-0002-5638-706X)
Abstract: Primary sclerosing cholangitis (PSC) is an immune-mediated chronic cholestatic liver disease and can progress to end-stage liver diseases such as liver cirrhosis and liver failure, and there are still no effective treatment methods at present. Studies have found that T lymphocytes are closely associated with the development and progression of PSC. This article reviews the role of T lymphocytes in PSC, so as to provide new ideas for research on the pathogenesis of PSC and the clinical diagnosis and treatment of PSC.
Key words: T lymphocytes; Primary Sclerosing Cholangitis; Pathogenesis
Research funding: Natural Science Foundation of Gansu Province (21JR1RA070); Hospital Fund of the First Hospital of Lanzhou University (ldyyyn2020-02, ldyyyn2020-14); Gansu Clinical Medieal Research Center of Infection & Liver Diseases (21JR7RA392); Gansu Provincial Higher Education Project on Innovation Ability Improvement (2020B-016)
原發(fā)性硬化性膽管炎(PSC)是一種免疫介導(dǎo)的慢性膽汁淤積性肝病,其特征是肝內(nèi)外膽管炎癥及纖維化導(dǎo)致多灶性膽管狹窄、慢性膽汁淤積,可進(jìn)展為肝硬化及終末期肝病,且患膽管癌的風(fēng)險(xiǎn)增加[1]。(剩余12867字)